• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

The immplication of crystal surface binding substances (CSBS) on urinary stone formation.

Research Project

Project/Area Number 06671588
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Urology
Research InstitutionOsaka University

Principal Investigator

YOSHIOKA Toshiaki  Osaka University, Dept.of Urology, Associate Professor, 医学部, 講師 (30191547)

Co-Investigator(Kenkyū-buntansha) HONDA Masahito  Osaka University, Dept.of Urology, Assistant Professor, 医学部, 助手 (70263291)
KOKADO Yukito  Osaka University, Dept.of Urology, Associate Professor, 医学部, 講師 (30186639)
Project Period (FY) 1994 – 1995
Project Status Completed (Fiscal Year 1995)
Budget Amount *help
¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 1995: ¥400,000 (Direct Cost: ¥400,000)
Fiscal Year 1994: ¥1,700,000 (Direct Cost: ¥1,700,000)
KeywordsCalcium oxalate crystal / Urinary macromolecules / Urinary stone / Urinary protein / 高分子物質
Research Abstract

Urinary macromolecules are considered to play a important role in stone formation. The aim of our study is to characterize the urinary protein affecting stone formation.
1.We obtained crystal surface binding substance (CSBS) by adding calcium and oxalate to human whole urine. The CSBS is urinary macromolecules absorbed onto the surface of calcium oxalate crystals and yields strong inhibitory activity on calcium oxalate crystallization. Proteins contained in the CSBS are analyzed.
2.Fractions enriched in proteins with strong calcium oxalate crystal growth inhibitory activity are obtained by DEAE-Sepharose CL-6B ion-chromatography. These fractions are fractionated by hydroxyapatite column with stepwise elution of sodium phosphate.
3.The SDS-PAGE shows many bands of protein. Two major proteins, molecular weight of 30Kd and 67Kd, are analyzed by a amino acid sequencer. As a result, 30Kd protein is identified with human prothrombin and 67Kd protein with human osteopontin.
4.Protein composition of fractions obtained by hydroxyapatite column is also analyzed by immunoblotting. Human serum albumin, alpha 1-acid glycoprotein, alpha 1-microglobulin, alpha 2-HS glycoprotein, retinol-binding protein, transferrin, Tamm-Horsfall mucoprotein and prothrombin are detected. However, it is considered that these proteins does not play a signifficant role on calcium oxalate crystal formation because each fractions containing each proteins reveal weak inhibitory power on crystal growth.
We conclude that other unknown proteins included in CSBS are thought to be dominant protein inhibitors.

Report

(3 results)
  • 1995 Annual Research Report   Final Research Report Summary
  • 1994 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] M.Honda: "Characterization of protein components of human urinary crystal surface binding substance." Urological Research.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] M.Honda: "Urolithiasis 1996" C.Y.C.Pak,G.M.Preminger,M.I.Resnick, 2 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] S.Yamaguchi: "Urolithiasis 1996" C.Y.C.Pak,G.M.Preminger,M.I.Resnick, 2 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] M.Honda: "Characterization of protein components of human urinary crystal surface binding substance." Urolithiasis 1996. 285-286 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary
  • [Publications] S.Yamaguchi: "Protein inhibitors isolated from calcium oxalate crystals." Urolithiasis 1996. 289-290 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1995 Final Research Report Summary

URL: 

Published: 1994-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi